148.74001 USD
5.32
3.45%
Last update Dec 16, 3:59 PM EST
Market closed
Day range
148.13499
155.23000
Previous close
154.059998
Open
155.23000
Access this stock data via API
Subscribe
Neurocrine Biosciences Inc.
148.74
5.32
3.45%

Financials

Income statement

Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 794.9M 687.5M 572.6M 627.7M
Cost of revenue 14M 11.3M 9.2M 9.3M
Gross profit 780.9M 676.2M 563.4M 618.4M
Operating expense
Research & development 250M 244.3M 263.2M 185.6M
Selling general and admin 291.6M 286.3M 276.5M 287.8M
Other operating expenses
Operating income 239.3M 145.6M 23.7M 145M
Non operating interest income
Income
Expense
Other income expense 52.5M 13.9M -9M 53.2M
Pretax income 291.8M 159.5M 14.7M 162.6M
Tax provision 82.3M 52M 6.8M 59.5M
Net income 209.5M 107.5M 7.9M 103.1M
Basic EPS 2.1 1.1 0.1 1.0
Diluted EPS 2.0 1.1 0.1 1
Basic average shares 99.4M 99M 99.7M 100M
Diluted average shares 102.5M 101M 102.5M 102.9M
EBITDA 194.5M 139M 40.3M 128.5M
Net income from continuing op. 209.5M 107.5M 7.9M 103.1M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Pre-market opens in 7 hours 58 minutes

20:01
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EST, UTC-05:00).